Should methotrexate be a first-line treatment for rheumatoid arthritis?

被引：1
作者：
Wilke, WS [1 ]
机构：
[1] Cleveland Clin Fdn, Dept Rheumat & Immunol Dis, Cleveland, OH 44195 USA
来源：
CLEVELAND CLINIC JOURNAL OF MEDICINE | 1999年 / 66卷 / 04期
关键词：
D O I：
10.3949/ccjm.66.4.207
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：207 / 208
页数：2
相关论文
共 17 条
  • [1] ALARCON GS, 1992, J RHEUMATOL, V19, P1868
  • [2] Bologna C, 1997, CLIN EXP RHEUMATOL, V15, P597
  • [3] Drosos AA, 1997, CLIN EXP RHEUMATOL, V15, P263
  • [4] USE OF SHORT-TERM EFFICACY TOXICITY TRADEOFFS TO SELECT 2ND-LINE DRUGS IN RHEUMATOID-ARTHRITIS - A METAANALYSIS OF PUBLISHED CLINICAL-TRIALS
    FELSON, DT
    ANDERSON, JJ
    MEENAN, RF
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (10): : 1117 - 1125
  • [5] THE RELATIVE TOXICITY OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
    FRIES, JF
    WILLIAMS, CA
    RAMEY, D
    BLOCH, DA
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (03): : 297 - 306
  • [6] PROPOSITION - METHOTREXATE SHOULD NOT BE THE 1ST 2ND-LINE AGENT TO BE USED IN RHEUMATOID-ARTHRITIS IF NSAIDS FAIL
    FURST, DE
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1990, 20 (02) : 69 - 75
  • [7] LIVER HISTOLOGY IN RHEUMATOID-ARTHRITIS PATIENTS RECEIVING LONG-TERM METHOTREXATE THERAPY - A PROSPECTIVE-STUDY WITH BASELINE AND SEQUENTIAL BIOPSY SAMPLES
    KREMER, JM
    LEE, RG
    TOLMAN, KG
    [J]. ARTHRITIS AND RHEUMATISM, 1989, 32 (02): : 121 - 127
  • [8] Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO
  • [9] 2-W
  • [10] SUPPLEMENTATION WITH FOLIC-ACID DARING METHOTREXATE THERAPY FOR RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    MORGAN, SL
    BAGGOTT, JE
    VAUGHN, WH
    AUSTIN, JS
    VEITCH, TA
    LEE, JY
    KOOPMAN, WJ
    KRUMDIECK, CL
    ALARCON, GS
    [J]. ANNALS OF INTERNAL MEDICINE, 1994, 121 (11) : 833 - 841
12